Nuofu Zhang to Anticoagulants
This is a "connection" page, showing publications Nuofu Zhang has written about Anticoagulants.
Connection Strength
0.046
-
Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism. Clin Chim Acta. 2016 Aug 01; 459:25-29.
Score: 0.035
-
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020 05; 7(5):e362-e363.
Score: 0.011